BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19859691)

  • 21. Insulin glargine and the risk of cancer.
    Ahmed FA
    Cardiovasc J Afr; 2010; 21(1):49. PubMed ID: 20224847
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The international study of insulin and cancer.
    Grimaldi-Bensouda L; Marty M; Pollak M; Cameron D; Riddle M; Charbonnel B; Barnett AH; Boffetta P; Boivin JF; Evans M; Rossignol M; Benichou J; Abenhaim L;
    Lancet; 2010 Sep; 376(9743):769-70. PubMed ID: 20816540
    [No Abstract]   [Full Text] [Related]  

  • 24. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
    Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin confusion: an observation.
    Phillips W; Lando H
    Diabetes Care; 2002 Jun; 25(6):1103-4. PubMed ID: 12032129
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin glargine (Lantus) and cancer risk.
    Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin glargine and its role in glycaemic management of Type 2 diabetes.
    Elrishi MA; Jarvis J; Khunti K; Davies MJ
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1099-110. PubMed ID: 18680444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.
    Edwards KL; Riche DM; Stroup JS; Goldman-Levine JD; Padiyara RS; Cross LB; Kane MP
    Pharmacotherapy; 2010 Sep; 30(9):955-65. PubMed ID: 20795850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin analogues.
    Marks J
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):8-12. PubMed ID: 19667599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lantus or lente insulin? The confusion builds.
    Cohen MR
    Nursing; 2003 Sep; 33(9):12. PubMed ID: 14562818
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relationship between diabetology and oncology. Cancer alarm initially without practical consequences].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):16, 18. PubMed ID: 19938774
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin glargine use and short-term incidence of malignancies - a three-year population-based observation.
    Ljung R; Talbäck M; Haglund B; Jonasson JM; Gudbjörnsdòttir S; Steineck G
    Acta Oncol; 2011 Jun; 50(5):685-93. PubMed ID: 21506898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insulin analogs: structure, properties and therapeutic indication. Part 2. Long-acting insulin analogs].
    Rosak C
    Internist (Berl); 2001 Dec; 42(12):1692-9. PubMed ID: 11793609
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin glargine.
    Bolli GB; Owens DR
    Lancet; 2000 Aug; 356(9228):443-5. PubMed ID: 10981882
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin glargine and cancer: another side to the story?
    Gale EA
    Lancet; 2009 Aug; 374(9689):521. PubMed ID: 19683632
    [No Abstract]   [Full Text] [Related]  

  • 38. Putting insulin glargine and malignancies into perspective.
    Ehninger G; Schmidt AH
    Oncologist; 2009 Dec; 14(12):1169-74. PubMed ID: 20007644
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin glargine. Glargine, HOE 71GT15, HOE 71GT80, HOE 901.
    Drugs R D; 1999 Aug; 2(2):107-9. PubMed ID: 10820651
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
    Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K;
    Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.